Ebook Sarcoma of the female genitalia (Vol 1): Part 1

The book provides a description at length of the epidemiology, etiology, pathological anatomy, prognosis, diagnosis, differential diagnosis, imaging and comprehensive therapy of each primary, relapsed, and metastasized tumor including surgery, chemo-, hormone- and radio- and targeted therapy.

Günter Köhler, Matthias Evert, Katja Evert, Marek Zygmunt Sarcoma of the female genitalia Günter Köhler, Matthias Evert, Katja Evert, Marek Zygmunt Sarcoma of the female genitalia | Volume 1: Smooth muscle and stromal tumors and prevention of inadequate sarcoma surgery In collaboration with Philipp-Andreas Hessler, Lars Kaderali, Hanka Lehnhoff, Lisa Linke Authors Prof Dr Günter Köhler Department of Obstetrics and Gynecology, University Medicine Greifswald and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors Ferdinand-Sauerbruch-Straße 17475 Greifswald, Germany e-mail: koehlerg@uni-greifswald.de Prof Dr Matthias Evert Institute of Pathology, University Hospital Regensburg and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors, Greifswald Franz-Josef-Strauß-Allee 11 93053 Regensburg, Deutschland e-mail: matthias.evert@ukr.de Prof Dr Marek Zygmunt Department of Obstetrics and Gynecology, University Medicine Greifswald and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors Ferdinand-Sauerbruch-Straße 17475 Greifswald, Germany e-mail: zygmunt@uni-greifswald.de Dr Katja Evert Institute of Pathology, University Hospital Regensburg and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors, Greifswald Franz-Josef-Strauß-Allee 11 93053 Regensburg, Deutschland e-mail: katja.evert@ukr.de Collaborators Dr Philipp-Andreas Hessler Department of Gynecologic Surgery, Center of Minimal-Invasive Surgery, Sachsenhausen, Frankfurt/Main/Germany Prof Dr Lars Kaderali Institute for Bioinformatics, University Medicine Greifswald/Germany Hanka Lehnhoff Department of Obstetrics and Gynecology University Medicine Greifswald, Germany and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors, Greifswald/Germany Lisa Linke Department of Obstetrics and Gynecology University Medicine Greifswald and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors, Greifswald/Germany ISBN 978-3-11-035141-5 e-ISBN (PDF) 978-3-11-035197-2 e-ISBN (EPUB) 978-3-11-038763-6 The publisher, together with the authors and editors, has taken great pains to ensure that all information presented in this work (programs, applications, amounts, dosages, etc.) reflects the standard of knowledge at the time of publication Despite careful manuscript preparation and proof correction, errors can nevertheless occur Authors, editors and publisher disclaim all responsibility and for any errors or omissions or liability for the results obtained from use of the information, or parts thereof, contained in this work The citation of registered names, trade names, trademarks, etc in this work does not imply, even in the absence of a specific statement, that such names are exempt from laws and regulations protecting trademarks etc and therefore free for general use Library of Congress Cataloging-in-Publication Data A CIP catalog record for this book has been applied for at the Library of Congress Bibliographic information published by the Deutsche Nationalbibliothek The Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data are available on the Internet at http://dnb.dnb.de © 2017 Walter de Gruyter GmbH, Berlin/Boston Cover image: Hackelöer HJ, Kreiselmaier P Facharzt-Zentrum für Kinderwunsch Pränatale Medizin, Endokrinologie u Osteologie, Amedes Experts Hamburg, Hamburg, Germany Translation into English: Dr jur Philip Horsfield, Greifswald/Germany ⟨translate@philiphorsfield.com⟩ Typesetting: PTP-Berlin, Protago-TEX-Production GmbH, Berlin Printing and binding: Hubert & Co GmbH und Co KG, Göttingen ♾ Printed on acid-free paper Printed in Germany www.degruyter.com Foreword This monograph, comprising two volumes, discusses typical sarcomas of the female genitalia, including angiosarcoma, liposarcoma and rhabdomyosarcoma as well as the different types of mixed tumors Other rare mesenchymal genital tumors are also comprehensively presented, such as the different variants of leiomyoma, smooth muscle tumors with uncertain malignant potential, endometrial stromal nodules, endometrial stromal tumors with sex cord-like elements (ESTSCLE), uterine tumor resembling ovarian sex-cord/stromal tumor (UTROCST) and PEComas The behavior of the aforementioned neoplasms in relation to, and in the context of fertility and pregnancy is covered in a separate chapter Another chapter is devoted to the prevention of subjecting sarcomas to inadequate surgical therapeutic measures under the assumed diagnosis of leiomyoma, and includes a diagnostic-therapeutic flowchart with a diagnostic score The following subsections are provided for each of the tumor entities listed above: epidemiology, etiology, macroscopy and microscopy, clinical presentation, diagnostics, imaging, differential diagnostics, prognosis, surgical and radiation therapy for the primary tumor or recurrences and metastases including primary, adjuvant and palliative chemotherapy, hormone therapy, targeted therapy and aftercare The substantial basis for this monograph comprises 1,681 fully documented sarcoma consultation cases of the German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors (“Deutsches klinisches Kompetenzzentrum für genitale Sarkome und Mischtumoren”, DKSM), University Medicine Greifswald/Germany, and the data kindly provided by our cooperation partners “Velener Working Group on Ambulatory Surgery” (“Velener Arbeitsgemeinschaft Ambulantes Operieren Deutschland”, VAAO) and the Department Gynecologic Surgery, Center of Minimal-Invasive Surgery, Sachsenhausen/Frankfurt Main/Germany The overriding aim of this monograph is to identify and provide therapeutic guidance on the basis of evaluation of the DKSM data performed by the DKSM doctoral research group “uterine sarcomas”, as well as on 2,025 literature sources, recommendations and studies published up to the end of May 2016 Particular attention has been devoted to determining, as far as possible, which measures can currently not be defined as standard practice In total, 576 figures and illustrations have been incorporated and are comprehensively described The listed tumor entities also constitute a particular diagnostic challenge for pathologists that is beset with numerous pitfalls and difficulties This monograph, therefore, addresses gynecologists and pathologists in both clinical and private practice, but also surgeons and hemato-oncologists VI | Foreword Sincere thanks must be extended to a total of 112 gynecologists, pathologists, radiologists, hemato-oncologists and medical practitioners in clinical and private practice, but also affected patients, who kindly provided figures, images and data for use in this monograph Greifswald and Regensburg, June 2016 Prof Dr G Köhler, Prof Dr M Zygmunt, Department of Obstetrics and Gynecology, University Medicine Greifswald and German Clinical Center of Excellence for Sarcomas and Mixed Tumors, Greifswald Prof Dr M Evert, Dr Katja Evert Institute of Pathology, University Hospital Regensburg and German Clinical Center of Excellence for Genital Sarcomas and Mixed Tumors, Greifswald Sarcoma of the female genitalia Volume 1: Smooth muscle and stromal tumors and prevention of inadequate sarcoma surgery (ISBN: 978-3-11-035141-5) Volume 2: Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy (ISBN: 978-3-11-045921-0) Contents Foreword | V List of abbreviations | XXI Definition of cytoreduction, NCCN-Guidelines | XXV Immunohistochemistry table | XXVI Volume Günter Köhler, Katja Evert, Marek Zygmunt and Matthias Evert Variants of leiomyoma (angio- and lipoleiomyoma, cotyledonoid and cellular leiomyoma, leiomyoma with bizarre nuclei, mitotically active, epithelioid and myxoid leiomyoma), smooth muscle tumors with uncertain malignant potential (atypical smooth muscle tumors), disseminated peritoneal leiomyomatosis, benign metastasizing leiomyoma, intravenous leiomyomatosis | 1.1 Angioleiomyoma (Angiomyoma, vascular leiomyoma) | 1.1.1 General, epidemiology, etiology, pathogenesis, pathological-anatomical findings | 1.1.2 Clinical presentation, diagnostics, imaging, differential diagnostics | 1.1.3 Course, prognosis, primary surgery, systemic and radiogenic therapy | 1.1.4 Aftercare, recurrences, metastases and their treatment | 1.2 Lipoleiomyoma | 1.2.1 General, pathogenesis, pathological-anatomical findings | 1.2.2 Clinical presentation, diagnostics, imaging, differential diagnostics | 1.2.3 Course, prognosis, primary surgery, systemic and radiogenic therapy | 1.3 Cotyledonoid dissecting leiomyoma | 1.3.1 General, pathogenesis, pathological-anatomical findings | 1.3.2 Clinical presentation, diagnostics, imaging, differential diagnostics | 1.3.3 Course, prognosis, primary surgery, systemic and radiogenic therapy | 216 | Leiomyosarcoma (125) (126) (127) (128) (129) (130) (131) (132) (133) (134) (135) (136) (137) (138) (139) (140) (141) (142) first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study J Clin Oncol 2015; 33:1180–1185 Hilliard NJ, Heslin MJ, Castro CY Leiomyosarcoma of the inferior vena cava: three case reports and review of the literature Ann Diagn Pathol 2005; 9: 259–266 Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP Multiple primary cancers in families with Li-Fraumeni syndrome J Natl Cancer Inst 1998; 90: 606–611 Hoang HL, Ensor K, Rosen G, Leon Pachter H, Raccuia JS Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma Int J Surg Oncol 2014; 2014: 919323 doi: 10.1155/2014/919323 Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer Gynecol Oncol 2004; 95: 546–551 Hsiao HH, Liu YC, Hou MF, LinSF Uterine leiomyosarcoma metastasis to the breast Eur J Gynaecol Oncol 2008; 29: 191–192 Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma Cancer 2013; 119: 1816–1822 Iihara K, Hirano K, Fujioka Y, Sakamoto A Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization Pathol Int 2007; 57: 681–687 Inoue D, Yamamoto M, Sugita G, Kurokawa T, Yoshida Y Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination Gynecol Oncol Rep 2015; 13: 60–63 Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C, Cass I Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles Gynecol Oncol 2009; 115: 466–471 Iribarne C, Plaza J, De la Fuente P, Garrido C, Garzon A, Olaizola J I Intramyometrial cystic adenomyosis J Clin Ultrasound 1994; 22: 348–350 Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, BaurMelnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase multicentre study Lancet Oncol 2010; 11: 561–570 Jaakkola S, Lyytinen HK, Pukkala E, Ylikorkala O Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas Gynecol Oncol 2011; 122: 260–263 Jacobs VR, Zemzoum I, Kremer M, Gottschalk N, Baumgärtner AK, Krol J, Kiechle M Primary metastatic leiomyosarcoma of the fallopian tube: a rare case report Onkologie 2010; 33: 49–52 Jacoby AF, Fuller AF Jr, Thor AD, Muntz HG Primary leiomyosarcoma of the fallopian tube Gynecol Oncol 1993; 51: 404–407 Jimenez WA, Sardi A, Nieroda C, Gushchin V Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination Am J Obstet Gynecol 2014; 210: 259.e1–8 Jones ISC, Crandou A, Sandav K Vulvar sarcomas: A 25 plus-year experience from Queensland Open Journal of Obstetrics and Gynecology 2013; 3: 37–40 Judson IR, Miah AB Uterine sarcoma dissemination during myomectomy: If not “acceptable collateral damage”, is it possible to mitigate the risk? Cancer 2014; 120: 3100–3102 Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, References | 217 (143) (144) (145) (146) (147) (148) (149) (150) (151) (152) (153) (154) (155) (156) (157) (158) Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase trial Lancet Oncol 2014; 15: 415–423 Kagami S, Kashimura M, Toki N, Katuhata Y Myxoid leiomyosarcoma of the uterus with subsequent pregnancy and delivery Gynecol Oncol 2002; 85: 538–542 Kanjeekal S, Chambers A, Fung MF, Verma S Systemic therapy for advanced uterine sarcoma: a systematic review of the literature Gynecol Oncol 2005; 97: 624–637 Kapp DS, Shin JY, Chan JK Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas Emphasis on impact of lymphadenectomy and oophorectomy Cancer 2008; 112: 820–830 Kasper B, Sleijfer S, Litière S, Marreaud S, Verweij J, Hodge RA, Bauer S, Kerst JM, van der Graaf WTA Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072 Ann Oncol 2014; 25: 719–724 Kawamura N, Ichimura T, Ito F, Shibata S, Takahashi K, Tsujimura A, Ishiko O, Haba T, Wakasa K, Ogita S Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma Cancer 2002; 94: 1713–1720 Kawamura N, Ichimura T, Takahashi K, Tsujimura A, Ishiko O, Ogita S Transcervical needle biopsy of uterine myoma-like tumors using an automatic biopsy gun Fertil Steril 2002; 77: 1060–1064 Kelly KL, Craighead PS Characteristics and management of uterine sarcoma patients treated at the Tom Baker Centre Int J Gynecol Cancer 2005; 15: 132–139 Khoury-Collado F, Einstein MH, Bochner BH, Alektiar KM, Sonoda Y, Abu-Rustum NR, Brown CL, Gardner GJ, Barakat RR, Chi DS Pelvic exenteration with curative intent for recurrent uterine malignancies Gynecol Oncol 2012; 124: 42–47 Kim HS, Han KH, Chung HH, Kim JW, Park NH, Song YS, Kang SB Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison Eur J Surg Oncol 2010; 36: 691–698 Kim NR, Cho HY, Ha SY Intramyometrial uterine cysts with special reference to ultrastructural findings: report of two cases J Obstet Gynaecol Res 2011; 37: 259–263 Kim JJ, Kurita T, Bulun SE Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer Endocr Rev 2013; 34: 130–162 Kitajima K, Murakami K, Kaji Y, Sugimura K Spectrum of FDG PET/CT findings of uterine tumors AJR Am J Roentgenol 2010; 195: 737–743 Klijanienko J, Caillaud JM, Lagacé R, Vielh P Fine-needle aspiration of leiomyosarcoma: a correlative cytohistopathological study of 96 tumors in 68 patients Diagn Cytopathol 2003; 28: 119–125 Kobayashi H, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Koike N, Shigetomi H The biology of uterine sarcomas: A review and update Mol Clin Oncol 2013; 1: 599–609 Köhler G, Belau A, Dennis K, Hesse J, Köller M, Krichbaum J, Kühnast M, Lehnhoff H, Lehr A, Linke L, Marcinek A, Müller S, Riechmann C, Schalitz S, Simon J, Spring P, Schädler, J, Ständer C, Trojnarska D, Wilcke S, Witte N, Zygmunt M.: Deutsches klinisches Kompetenzzentrum für genitale Sarkome und Mischtumoren an der Universitätsmedizin Greifswald (DKSM) und Kooperationspartner VAAO Deutschland und FK Frankfurt/Sachsenhausen DKSMDatenbank und Promotions- und Forschungsgruppe genitale Sarkome, Greifswald 2016, http://www.medizin.uni-greifswald.de/gyn/dksm/ Koivisto-Korander R, Leminen A, Heikinheimo O Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma Obstet Gynecol 2007; 109: 512–514 218 | Leiomyosarcoma (159) Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001 Gynecol Oncol 2008; 111: 74–81 (160) Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases Maturitas 2012; 72: 56–60 (161) Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, Ishiko O, Motoyama S, Fujii S, Umesaki N Clinical outcomes of uterine sarcomas: results from 14 years’ worth of experience in the kinki district in Japan (1990–2003) Int J Gynecol Cancer 2006; 16: 1358–1363 (162) Kurjak A, Zalud I The characterization of uterine tumors by transvaginal color Doppler Ultrasound Obstet Gynecol 1991; 1: 50–52 (163) Kurjak A, Kupesic S, Shalan H, Jukic S, Kosuta D, Ilijas M Uterine sarcoma: a report of 10 cases studied by transvaginal color and pulsed Doppler sonography Gynecol Oncol 1995; 59: 342–346 (164) Lajer H, Jensen MB, Kilsmark J, Albæk J, Svane D, Mirza MR, Geertsen PF, Reerman D, Hansen K, Milter MC, Mogensen O The value of gynecologic cancer follow-up: evidencebased ignorance? Int J Gynecol Cancer 2010; 20: 1307–1320 (165) Lang H, Nußbaum KT, Kaudel P, Frühauf N, Flemming P, Raab R Hepatic metastases from leiomyosarcoma A single-center experience with 34 liver resections during a 15-year period Ann Surg 2000; 231: 500–505 (166) Lebedinsky C, Gomez J, Park YC, Nieto A, Soto-Matos A, Parekh T, Alfaro V, Roy E, Lardelli P, Kahatt C Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis Cancer Chemother Pharmacol 2011; 68: 1223–31 (167) Lee WY, Tzeng CC, Chou CY Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist Gynecol Oncol 1994; 52: 74–79 (168) Leibsohn S, d’Ablaing G, Mishell DR Jr, Schlaerth JB Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 1990; 162: 968–974 (169) Leitao MM, Brennan MF, Hensley M, Sonoda Y, Hummer A, Bhaskaran D, Venkatraman E, Alektiar K, Barakat RR Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma Gynecol Oncol 2002; 87: 287–294 (170) Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol Oncol 2003; 91: 209–212 (171) Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 2004; 101: 1455–1462 (172) Leitao MM, Hensley Ml, Barakat RR, Aghajanian C, Gardner GJ, Jewell EL, O’Cearbhaill R, Soslow RA Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcomas Gynecol Oncol 2012; 124: 558–562 (173) Leitao MM Jr, Zivanovic O, Chi DS, Hensley ML, O’Cearbhaill R, Soslow RA, Barakat RR Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis Gynecol Oncol 2012; 125: 409–413 (174) Leitao MM, Tornos C, Wolfson A, O´Cearbhaill R Corpus: mesenchymal tumors In: Barakat RR, Berchuk A, Markman M, Randall ME (eds.) Principles and Practice of Gynecologic Oncology 6th edn Lippincott Williams & Wilkins: Philadelphia 2013, online ed pos 47172–74393 References | 219 (175) Lerman H, Bar-On S, Helpman L, Even-Sapir E, Grisaru D Estrogen-dependent variations in 18f-fluorodeoxyglucose uptake in uterine leiomyomas Int J Gynecol Cancer 2012; 22: 1187–1191 (176) Lerwill MF, Sung R, Oliva E, Prat J, Young RH Smooth muscle tumors of the ovary: a clinicopathologic study of 54 cases emphasizing prognostic criteria, histologic variants and differential diagnosis Am J Surg Pathol 2004; 28: 1436–1451 (177) Leung F, Terzibachian JJ Re: “The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma” Gynecol Oncol 2012; 124: 172–173 (178) Levenback C, Rubin SC, McCormack PM, Hoskins WJ, Atkinson EN, Lewis JL Resection of pulmonary metastases from uterine sarcomas Gynecol Oncol 1992; 45: 202–205 (179) Levy RA, Winham WM, Bryant CS, Quick CM Smooth muscle neoplasms of the vulva masquerading as Bartholin gland duct cysts Proc Bayl Univ Med Cent 2014; 27: 25–27 (180) Li L, Wang SZ, Zhang ZY, Zhai Y, Jiang HC, Li J Follow-up of benign gynecologic diseases in patients treated with tamoxifen for breast cancer Zhonghua Yi Xue Za Zhi 2010; 90: 1735–1738 (Abstr.) (181) Lim D, Wang WL, Lee CH, Dodge T, Gilks B, Oliva E Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases Gynecol Oncol 2013; 128: 322–326 (182) Lin KH, Torng PL, Tsai KH, Shih HJ, Chen CL Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma Taiwan J Obstet Gynecol 2015; 54: 172–177 (183) Lissoni A, Cormio G, Bonazzi C, Perego P, Lomonocio S, Gabriele A, Bratina G Fertility sparing surgery in uterine leiomyosarcoma Gynecol Oncol 1998; 70: 348–350 (184) Look KY, Sandler A, Blessing JA, Lucci JA, Rose PG: Oncology Group (GOG) Study Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study Gynecol Oncol 2004; 92: 644–647 (185) Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study J Clin Oncol 2007; 25: 3144–3150 (186) Major F, Blessing J, Silverberg S, Morrow P, Creasman W, Curry JL, Yordan E, Brady MF Prognostic factors in early stage uterine sarcoma: a gynecologic oncology study Cancer 1993; 71: 1702–1709 (187) Maluccio MA, Covey AM, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, DeMatteo R, Brown KT Treatment of metastatic sarcoma to the liver with bland embolization Cancer 2006; 107: 1617–1623 (188) Mancari R, Signorelli M, Gadducci A, Carinelli S, De Ponti E, Sesana S, Corso S, Chiappa V, Colombo N, Lissoni AA Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: A multicentric retrospective study of 140 patients Gynecol Oncol 2014; 133: 531–536 (189) Massi D, Franchi A, Alos L Cook M, Di Palma S, Enguita AB, Ferrara G: Kazakov DV, Mentzel T, Michal M, Panelos J, Rodriguez-Peralto JL, Santucci M, Tragni G, Zioga A, Dei Tos AP Primary cutaneous leiomyosarcoma: clinicopatholoqical analysis of 36 cases Histopathology 2010; 56: 251–262 (190) Matsuda M, Ichimura T, Kasai M, Murakami M, Kawamura N, Hayashi T, Sumi T Preoperative diagnosis of usual leiomyoma, atypical leiomyoma, and leiomyosarcoma Sarcoma 2014; 2014: 498682 doi: 10.1155/2014/498682 220 | Leiomyosarcoma (191) Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Obermair A, Kimberger O, Czerwenka K Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma Gynecol Oncol 2004; 92: 175–179 (192) Melone GA, D’Elia A, Brogna C, Salvati M Uterine leiomyosarcoma metastatic to the brain: case report Tumori 2008; 64: 856–860 (193) Mendivil AA, Cupp JS, Van Dalsemc W, Caffarellid A, Goldstein BH Multidisciplinary treatment of pelvic and cardiac intravenous leiomyosarcomatosis Gynecol Oncol Rep 2013; 6: 16–18 (194) Menge F, Hartmann E, Mathew M, Kasper B, Hohenberger P The impact of operative techniques to the onset of peritoneal tumor dissemination in parients with uterine Leiomyosarcomas 18th Annual Meeting of Connective Tissue Oncology Society 2013; Paper 010 (195) Mills AM, Ly A, Balzer BL, Hendrickson MR, Kempson RL, McKenney JK, Longacre TA Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up Am J Surg Pathol 2013; 37: 634–642 (196) Milman D, Zalel Y, Biran H, Open M, Caspi B, Hagay Z, Dgani R Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review Eur J Obstet Gynecol Reprod Biol 1998; 76: 237–240 (197) Mittal K, Popiolek D, Demopoulos RI Uterine myxoid leiomyosarcoma within a leiomyoma Hum Pathol 2000; 31: 398–400 (198) Mittal K, Demopoulos RI MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors Hum Pathol 2001; 32: 984–987 (199) Mittal K, Joutovsky A Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas Gynecol Oncol 2007; 104: 362–365 (200) Mittal KR, Chen F, Wei JJ, Rijhvani K, Kurvathi R, Streck D, Dermody J, Toruner GA Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas Mod Pathol 2009; 22: 1303–1311 (201) Monk BJ, Nieberg R, Berek JS Primary leiomyosarcoma of the ovary in a perimenarchal female Gynecol Oncol 1993; 48: 389–393 (202) Monk BJ, Blessing JA, Street DG, Muller CY, Burke JJ, Hensley ML A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study Gynecol Oncol 2012; 124: 48–52 (203) Morice P, Rodriguez A, Rey A, Pautier P, Atallah D, Genestie C, Pomel C, Lhommé C, HaieMeder C, Duvillard P, Castaigne D Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients Eur J Gynaecol Oncol 2003; 24: 237–240 (204) Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment Radiographics 1999; 19: 1179–1197 (205) Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T, Hachisuga T, Ito K, Uno T, Katsumata N, Komiyama S, Susumu N, Emoto M, Kobayashi H, Metoki H, Konishi I, Ochiai K, Mikami M, Sugiyama T, Mukai M, Sagae S, Hoshiai H, Aoki D, Ohmichi M, Yoshikawa H, Iwasaka T, Udagawa Y, Yaegashi N; Japan Society of Gynecologic Oncology Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition Int J Clin Oncol 2010; 15: 531–542 (206) Nakayama K, Nakayama N, Rahman MT, Rahman M, Katagiri H, Katagiri A, Ishikawa M, Ishibashi T, Iida K, Harada Y, Miyazaki K Uterine leiomyosarcoma producing granulocyte colony stimulating factor Int J Gynecol Pathol 2012; 31: 172–177 (207) Naqamatsu A, Umesaki N, Li L, Tanaka T Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas Oncol Rep 2010; 23: 1069–1076 References | 221 (208) Nasu K, Kawano Y, Hirota Y, Matsui N, Hayata T, Miyakawa I Immunohistochemical study of c-erb B-2 expression in malignant mixed müllerian tumors of the female genital tract J Obstet Gynaecol Res 1996; 22: 347–351 (209) National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology – Soft Tissue Sarcoma – Version 2.2016 www.nccn.org (210) National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology – Uterine neoplasms – Version 2.2016 www.nccn.org (211) Nemec W, Inwald EC, Buchholz S, Klinkhammer Schalke M, Gerken M, Ortmann O Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma Arch Gynecol Obstet 2016 Apr 22 doi 10.1007/s00404-016-4086-x (212) Newman PL, Fletcher CDM Smooth muscle tumours of the external genitalia: Clinicopathological analysis of a series Histopathologic 1991; 18: 523–529 (213) Ngan HY, Fisher C, Blake P, Shepherd JH Vaginal sarcoma: the Royal Marsden experience Int J Gynecol Cancer 1994; 4: 337–341 (214) Nicolas MM, Tamboli P, Gomez JA, Czerniak BA Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases Hum Pathol 2010; 411: 663–671 (215) Nielsen GP, Rosenberg AE, Koerner FC, Young RH, Scully RE Smooth-muscle tumors of the vulva: a clinicopathological study of 25 cases and review of the literature Am J Surg Pathol 1996; 20: 779–793 (216) Nordal RR, Thoresen SO Uterine sarcomas in Norway 1956–1992: incidence, survival and mortality Eur J Cancer 1997; 33: 907–911 (217) Nucci MR, Quade BJ Uterine mesenchymal tumors In: Crum P C, Nucci MR, Lee K R (eds.) Diagnostic Gynecologic and Obstetric Pathology 2nd edn Elsevier-Saunders: Philadelphia 2011; 582–639 (218) Nygaard I Laparoscopic hysterectomy: weigh harms, but not dismiss benefits Am J Obstet Gynecol 2015; 212: 553–555 (219) O’Cearbhaill R, Zhou Q, Iasonos A, Soslow RA, Leitao MM, Aghajanian C, Hensley ML Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors Gynecol Oncol 2010; 116: 424–429 (220) Oduyebo T, Rauh-Hain AJ, Meserve EE, Seidman MA, Hinchcliff E, George S, Quade B, Nucci MR, Del Carmen MG, Muto MG The value of re-exploration in patients with inadvertently morcellated uterine sarcoma Gynecol Oncol 2014; 132: 360–365 (221) Oliva E Leiomyoma and variants In: Nucci MR, Oliva E (eds) Diagnostic Pathology Gynaecological Amirsys 2014; 3-180–3-191 (222) Oliva E, Caracangiu ML, Carinelli SG, Ip P, Loening T, Longacre TA, Nucci MR, Prat J, Zaloudek CJ Tumors of the uterine corpus Mesenchymal tumors In: Kurman Rj, Carcangiu ML, Herrington CS, Young RH (eds): WHO Classification of Tumors of Female Reproductive Organs 4th edn IARC: Lyon 2014; 135–152 (223) Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT A randomized study of adriamycin with and without dimethyltriazenolimidazole carboxamide in advanced uterine sarcomas Cancer 1983; 52: 626–632 (224) Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study J Clin Oncol 1985; 3: 1240–1245 (225) O’Neill CJO, McBride HA, Connolly LE, McCluggage WG Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential Histopathology 2007; 50: 851–858 222 | Leiomyosarcoma (226) Orii A, Mori A, Zhai YL, Toki T, Nikaido T, Fujii S Mast cells in smooth muscle tumors of the uterus Int J Gynecol Pathol 1998; 17: 336–342 (227) O’Sullivan SG, Narta LD, Ferraro E Primary ovarian leiomyosarcoma in an adolescent following radiation for medulloblastoma Pediatr Radiol 1998; 28: 468–470 (228) Palussière J, Italiano A, Descat E, Ferron S, Cornélis F, Avril A, Brouste V, Bui BN Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients Ann Surg Oncol 2011; 18: 3771–3777 (229) Pang SJ, Li CC, Shen Y, Liu YZ, Shi YQ, Liu YX Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors Int J Clin Exp Pathol 2015; 8: 4418–4426 (230) Papadia A, Salom EM, Fulcheri E, Ragni N Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature Gynecol Oncol 2007; 104: 260–263 (231) Parikh JH, Barton DP, Ind TE, Sohaib SA MR imaging features of vaginal malignancies Radio Graphics 2008; 28: 49–63 (232) Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma Gynecol Oncol 2011; 122: 255–259 (233) Parker WH, Fu YS, Berek JS Uterine sarcomas in patients operated for presumed leiomyoma and rapidly growing leiomyoma Obstet Gynecol 1994; 83: 414–418 (234) Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhomme C, Haie-Meder C, Duvillard P Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 2000; 88: 1425–1431 (235) Pautier P, Floquet A, Penel N, Pipemo-Neumann S, Isambert N, Rey A, Bompas E, Cioffi A, Delcambre C, Cupissol D, Collin F, Blay JY, Jimenez M, Duffaud F Randomized multicenter and stratified phase II study of qemcitabine alone versus qemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study) Oncologist 2012; 17: 1213–1220 (236) Pautier P, Floquet A, Chevreau C, Penel N, Guillemet C, Delcambre C, Cupissol D, Selle F, Isambert N, Piperno-Neumann S, Thyss A, Bertucci F, Bompas E, Alexandre J, Collard O, Lavau-Denes S, Soulié P, Toulmonde M, Le Cesne A, Lacas B, Duffaud F; French Sarcoma Group Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase trial Lancet Oncol 2015; 4: 457–464 doi: 10.1016/S1470-2045(15)70070-7 (237) Pavlakis K, Messini I, Papadimitriou CA, Zagouri F, Yiannou P, Mavrelos D, Panoskaltis T Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal tumor Eur J Gynaecol Oncol 2011; 32: 362–363 (238) Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, Semelka RC, Kowalik A, Armao D, Davis B, Baird DD Growth of uterine leiomyomata among premenopausal black and white women Proc Natl Acad Sci USA 2008; 105: 19887–19892 (239) Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer 2009; 19: 257–260 (240) Plasvsic SK, Patham B, Honemeyer U, Kurjak A Uterine lesions: advances in ultrasound diagnosis In: Kurjak A, Chervenak FA (eds.) Donald School Textbook of Ultrasound in Obstetrics and Gynecology 3rd edn Jaypee Brothers Medical Publishers LTD 2011; 770–787 (241) Pollack SM, Loggers ET, Rodler ET, Yee C, Jones RL Immune-based therapies for sarcoma Sarcoma 2011; doi: 10.1155/2011/438940 References | 223 (242) Posy HE, Elkas JC, Yemelyanova AV, Diaz-Montes TP, Bristow RE, Giuntoli RL Metastatic leiomyosarcoma diagnosed after uterine artery embolization Eur J Gynaecol Oncol 2009; 30: 199–202 (243) Pothuri B, Kehoe M, Wright T, Herzog T Clinical outcome of atypical uterine smooth muscle tumors ASCO, Annual Meeting 2006, Abstr 15028 (244) Protopapas A, Milingos S, Markaki S, Loutradis D, Haidopoulos D, Sotiropoulou M, Antsaklis A Cystic uterine tumors Gynecol Obstet Invest 2008; 65: 275–280 (245) Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton, CC Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling Genes Chromosomes Cancer 2004; 40: 97–108 (246) Rauh-Hain JA, Oduyebo T, Diver EJ, Guseh SH, George S, Muto MG, del Carmen MG Uterine leiomyosarcoma: an updated series Int J Gynecol Cancer 2013; 23: 1036–1043 (247) Rauh-Hain JA1, Hinchcliff EM, Oduyebo T, Worley MJ Jr, Andrade CA, Schorge JO, George S, Muto MG, Del Carmen MG Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma Int J Gynecol Cancer 2014; 24: 1434–1440 (248) Ray-Coquard I, Rizzo E, Blay JY, Casali P, Judson I, Hansen AK, Lindner LH, Dei Tos AP, Gelderblom H, Marreaud S, Litière S, Rutkowski P, Hohenberger P, Gronchi A, van der Graaf WT Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy Gynecol Oncol 2016; 142: 95–101 (249) Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European organisation for research and treatment of cancer gynaecological cancer group study (protocol 55874) Eur J Cancer 2008; 44: 808–818 (250) Reed NS The management of uterine sarcomas Clin Oncol 2008; 20: 470–478 (251) Ren W, Korchin B, Lahat G, Wie C, Bolshakov S, Nguyen T, Merritt W, Dicker A, Lazar A, Sood A, Pollock RE, Lev D Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma Clin Cancer Res 2008; 14: 5466–5475 (252) Ricci S, Giuntoli RL, Eisenhauer E, Lopez MA, Krill L, Tanner EJ, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecol Oncol 2013; 131: 629–633 (253) Roque DR, Taylor KN, Palisoul M, Wysham WZ, Milam B, Robison K, Gehrig PA, Raker C, Kim KH Gemcitabine and docetaxel compared with observation, radiation, or other chemotherapy regimens as adjuvant treatment for stage I-to-IV uterine leiomyosarcoma Int J Gynecol Cancer 2016; 26: 505–512 (254) Rutstein SE, Siedhoff MT, Geller EJ, Doll KM, Wu JM, Clarke-Pearson DL, Wheeler SB Costeffectiveness of laparoscopic hysterectomy with morcellation compared to abdominal hysterectomy for presumed fibroids J Minim Invasive Gynecol 2015; 13 pii: S15534650(15)01618-0 doi: 10.1016/j.jmig.2015.09.025 (255) Sadeghi R, Zakavi SR, Hasanzadeh M, Treglia G, Giovanella L, Kadkhodayan S Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature Int J Gynecol Cancer 2013; 23: 1349–1356 224 | Leiomyosarcoma (256) Sagae S, Yamashita K, Ishioka S, Nishioka Y, Terasawa K, Mori M, Yamashiro K, Kanemoto T, Kudo R Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan Oncology 2004; 67: 33–39 (257) Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH MR imaging of uterine sarcomas AJR Am J Roentgenol 2001; 177: 1307–1311 (258) Salman MC, Guler OT, Kucukali T, Karaman N, Ayhan A Fertility-saving surgery for low-grade uterine leiomyosarcoma with subsequent pregnancy Int J Gynaecol Obstet 2007; 98: 160–161 (259) Salvati M, Cervoni L, Caruso R, Gagliardi FM, Delfini R Sarcoma metastatic to the brain: a series of 15 cases Surg Neurol 1998; 49: 441–444 (260) Sandruck J, Escobar P, Lurain J, Fishman D Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature Gynecol Oncol 2004; 92: 701–704 (261) Sanfilippo R, Grosso F, Jones RL, Banerjee S, Pilottic S, D’lncalcid M, Tos APD, Raspagliesi F, Judson I, Casali PG Trabectedin in advanced uterine leiomyosarcomas: A retrospective case seriesanalysis from two reference centers Gynecol Oncol 2011; 123: 553–556 (262) Sato K, Yuasa N, Fujita M, Fukushima Y Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma Am J Obstet Gynecol 2014; 210: 368.e1–8 (263) Schöffski P, Ray-Coquard IL, Cioffi A, Bui NB, Bauer S, Hartmann JT, Krarup-Hansen A, Grünwald V, Sciot R, Dumez H, Blay JY, Le Cesne A, Wanders J, Hayward C, Marreaud S, Ouali M, Hohenberger P European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) Activity of eribulin mesylatein patients with softtissue sarcoma: A phase study in four independent histological subtypes ASCO 15th Annual Meeting, Abstract # LBA10502 (264) Schütte J, Hartmann JH, Reichardt P, Issels RD, Tunn PU, Budach V Weichteilsarkome – Onkopedia Leitlinie 2011 http://www.dgho-onkopedia.de/de/onkopedia/leitlinien/ weichteilsarkome (265) Schwartz LB, Diamond MP, Schwartz PE Leiomyosarcomas: clinical presentation Am J Obstet Gynecol 1993; 168: 180–183 (266) Seddon BM, Scurr MR, Jones RL, Wood Z, Propert-Lewis C, A’Hern R, Whelan JS, Judson IR Phase II study of gemcitabine and docetaxel as first-line chemotherapy in locally advanced/ metastatic leiomyosarcoma J Clin Oncol 2009; 27: Suppl., abstr 10528 (267) Seddon B, Scurr M, Jones RL, Wood Z, Propert-Lewis C, Fisher C, Flanagan A, Sunkersing J, A’Hern R, Whelan J, Judson I A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma Clin Sarcoma Res 2015; 5: 13 doi: 10.1186/s13569-015-0029-8 (268) Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms PLoS One 2012; 7(11): e50058 doi: 10.1371/journal.pone.0050058 (269) Shadbolt CL, Coakley FV, Qayyum A, Donat SM MRI of vaginal leiomyoma J Comput Assist Tomogr 2001; 25: 355–357 (270) Sharma P, Kumar R, Singh H, Jeph S, Sharma JB, Jain SK, Sharma DN, Bal C, Malhotra A Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging Nucl Med Commun 2012; 33: 185–190 (271) Shin YR, Rha SE Miscellaneous Tumors of the uterus In: Kim SH (ed.) Radiology Illustrated Gynecologic Imaging 2nd edn Springer 2012; 249–297 (272) Shirafuji A, Shinagawa A, Kurokawa T, Yoshida Y Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report Oncol Lett 2014; 8: 637–641 References | 225 (273) Siedhoff MT, Wheeler SB, Rutstein SE, Geller EJ, Doll KM, Wu JM, Clarke-Pearson DL Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis Am J Obstet Gynecol 2015; 212: 591.e1–8 doi: 10.1016/j.ajog.2015.03.006 (274) Sizzi O, Rossetti A, Malzoni M, Minelli L, La Grotta F, Soranna L, Panunzi S, Spagnolo R, Imperato F, Landi S, Fiaccamento A, Stola E Italian multicenter study on complications of laparoscopic myomectomy J Minim Invasive Gynecol 2007; 14: 453–462 (275) Sobin LH, Gospadarowicz MK, Wittekind CH (eds.) TMN Classification of Malignant Tumours, 7th edn John Wiley & Sons 2009 (276) Stavrou GA, Flemming P, Oldhafer KJ Liver resection for metastasis due to malignant mesenchymal tumours HBP (Oxford) 2006; 8: 110–113 (277) Suh MJ, Park DC Leiomyosarcoma of the vagina: a case report and review from the literature J Gynecol Oncol 2008; 19: 261–264 (278) Stubbe F, Agaimy A, Ott O, Lettmaier S, Vassos N, Croner R, Hohenberger W, Fietkau R, Semrau S Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience Cancer Radiother 2016; 20: 6–13 (279) Sutton GP, Blessing JA, Barrett RJ, McGehee R Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: A Gynecologic Oncology Group study Am J Obstet Gynecol 1992; 166: 556–559 (280) Sutton G, Blessing JA, Malfetano JH Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus A gynecologic Oncology Group Study Gynecol Oncol 1996, 62: 226–229 (281) Sutton G, Blessing J, Hanjani P, Kramer P Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 2005; 96: 749–752 (282) Svarvar C, Böhling T, Berlin O, Gustafson P, Follerås G, Bjerkehagen B, Domanski HA, Sundby Hall K, Tukiainen E, Blomqvist C; Scandinavian Sarcoma Group Leiomyosarcoma Working Group.Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group Cancer 2007; 109: 282–291 (283) Szabó I, Szánthó A, Csabay L, Csapó Z, Szirmai K, Papp Z Color Doppler ultrasonography in the differentiation of uterine sarcomas from uterine leiomyomas Eur J Gynaecol Oncol 2002; 23: 29–24 (284) Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Friesenbichler J, Trajanoski S, Stojakovic T, Eberhard K, Leithner A, Pichler M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas Int J Cancer 2014; 135: 362–370 (285) Takeuchi K, Sugimoto M, Yoshida A, Yamashita S, Tsujino T, Nishino R Spontaneous uterine perforation secondary to leiomyosarcoma arising in a uterine leiomyoma Open Journal of Obstetrics and Gynecology 2014; 4: 186–189 (286) Tamura R, Kashima K, Asatani M, Nishino K, Nishikawa N, Sekine M, Serikawa T, Enomoto T Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging Int J Gynecol Cancer 2014; 24: 1042–1047 (287) Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings J Magn Reson Imaging 2004; 20: 998–1007 (288) Tasci T1, Karalok A, Taskin S, Ureyen I, Kımyon G, Tulek F, Ozfuttu A, Turan T, Tulunay G, Kose MF, Ortac F Does lymphadenectomy improve survival in uterine leiomyosarcoma? Int J Gynecol Cancer 2015; 25: 1031–103 226 | Leiomyosarcoma (289) Taşkin S, Takin EA, Uzỹm N, Ataolu O, Ortaỗ F Primary ovarian leiomyosarcoma: a review of the clinical and immunohistochemical features of the rare tumor Obstet Gynecol Surv 2007; 62: 480–486 (290) Tavassoli FA, Norris HJ Smooth muscle tumors of the vulva Obstet Gynecol 1979; 53: 213–217 (291) Tavassoli FA, Norris HJ Smooth muscle tumors of the vagina Obstet Gynecol 1979; 53: 689–693 (292) Thanopoulou E, Thway K, Khabra K, Judson I Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors Clin Sarcoma Res 2014; 26; 4–5 doi: 10.1186/2045-33294-5, eCollection 2014 (293) Tjalma WAA, Colpaert CGA Myxoid leiomyosarcomas of the vulva Gynrcol Oncol 2005; 96: 548–551 (294) Toledo G, Oliva E Smooth muscle tumors of the uterus Arch Pathol Lab Med 2008; 132: 595–605 (295) Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases Int J Cancer 2006; 119: 2922–2930 (296) Trojani M, Contesso G: Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 1984: 33: 37–42 (297) Trovik J, Salvesen HB, Cuppens T, Amant F, Staff AC Growth differentiation factor-15 as biomarker in uterine sarcomas Int J Gynecol Cancer 2014; 24: 252–259 (298) Tsao MN, Rades D, Wirth A, Lo S, Danielson BL, Gaspar LE, Sperduto PW, Vogelbaum MA, Radawski JD, Wang JZ, Gillin MT, Mohideen N, Hahn CA, Chang EL Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2012; 2: 210–225 (299) Tsikouras P, Liberis V, Galazios G, Savidis A, Grapsa A, Grapsa X, Teichmann AT, Maroulis G Uterine sarcoma: a report of 57 cases over a 16-year period analysis Eur J Gynaecol Oncol 2008; 29: 129–134 (300) Tsuyoshi H, Yoshida Y, Kurokawa T, Kotsuji F Diagnosis and management of leiomyosarcoma arising from ovarian vein: Case report and literature review J Obstet Gynaecol Res 2012; 38: 466–470 (301) Ueda T, Emoto M, Fukuoka M, Miyahara D, Horiuchi S, Tsujioka H, Kawarabayashi T Primary leiomyosarcoma of the fallopian tube Int J Clin Oncol 2010; 15: 206–209 (302) Umesaki N, Tanaka T, Miyama M, Ogita S, Kawabe J, Okamura T, Koyama K, Ochi H Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report Clin Imag 2001; 25: 203–205 (303) Van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase trial Lancet 2012; 379: 1879–1886 (304) Vasiljevic M, Stanojevic D, Djukic M, Hajric A Leiomyosarcoma of the uterine corpus with ovarian metastases in a 28-year-old woman: case report Eur J Gynaecol Oncol 2008; 29: 98–100 (305) Veras E, Malpica A, Deavers MT, Silva EG Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study Int J Gynecol Pathol 2009; 28: 316–321 References | 227 (306) Veras E, Zivanovic O, Jacks L, Chiappetta D, Hensley M, Soslow R “Low-grade leiomyosarcoma” and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas Am J Surg Pathol 2011; 35: 1626–1637 (307) Vilos GA, Hollett-Caines J, Abu-Rafea B, Allen HH, Inculet R, Kirk ME Leiomyosarcoma diagnosed six years after laparoscopic electromyolysis J Obstet Gynaecol Can 2008; 30: 500–504 (308) Walker CL, Stewart EA Uterine fibroids: the elephant in the room Science 2005; 308: 1589–1592 (309) Weiser MR, Downey RJ, Leun DH, Brennan MF Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma Am Coll Surg 2000; 191: 184–190 (310) Weiss SW, Goldblum JR Leiomyosarcoma In: Enzinger and Weiss’s Soft Tissue Tumors 5th edn Mosy Elsevier 2008; 545–564 (311) Wittekind C, Comptom CC, Brierley J, Sobin LH TNM-Supplement – a commentary on uniform use 4th edn UICC and John Wiley & Sons 2012 (312) Wong P, Han K, Sykes J, Catton C, Laframboise S, Fyles A, Manchul L, Levin W, Milosevic M Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcomas Radiat Oncol 2013; 8: 128 (313) Wright JD, Seshan VE, Shah M, Schiff PB, Burke WM, Cohen CJ, Herzog TJ The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma Am J Obstet Gynecol 2008; 199: 536.e1–8 (314) Wroński M, de Palma P, Arbit E Leiomyosarcoma of the uterus metastatic to brain: a case report and a review of the literature Gynecol Oncol 1994; 54: 237–241 (315) Xing D, Scangas G, Nitta M, He L, Xu X, Ioffe YJ, Aspuria PJ, Hedvat CY, Anderson ML, Oliva E, Karlan BY, Mohapatra G, Orsulic S A role for BRCA1 in uterine leiomyosarcoma Cancer Res 2009; 69: 8231–8235 (316) Yanai H, Wani Y, Notohara K, Takada S, Yoshino T Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review Pathol Int 2010; 60: 506–509 (317) Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma Am J Roentgenol 2000; 75: 759–766 (318) Yang DM, Kim HC, Jina W, Leeb JM, Limc SJ, Limd JW Leiomyosarcoma of the vagina: MR findings Clin Imaging 2009; 33: 482–484 (319) Yang SH, Chien JC, Chen CL, Chan WP Leiomyosarcoma of ovarian vein compression as a cause of hydronephrosis Eur J Gynaecol Oncol 2011; 32: 336–338 (320) Yavuz E, Gỹllỹolu MG, Akba N, Tuzlali S, Ilhan R, Iplikỗi A, Akhan SE The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms Pathol Int 2001; 51: 938–941 (321) Yildirim Y, Inal MM, Sanci M, Yildirim YK, Mit T, Polat M, Tinar S Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases Int J Gynecol Cancer 2005; 15: 1239–1242 (322) Yin P, Roqueiro D, Huang L, Owen JK, Xie A, Navarro A, Monsivais D, Coon JS, Kim JJ, Dai Y, Bulun SE Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells PLoS One 2012; 7(1): e29021 (323) Yoshida C, Ichimura T, Kawamura N, Nakano A, Kasai M, Sumi T, Ishiko O A scoring system for histopathologic and immunohistochemical evaluations of uterine leiomyosarcomas Oncol Rep 2009; 22: 725–731 228 | Leiomyosarcoma (324) Zafrakas M, Zepiridis L, Theodoridis TD, Venizelos ID, Papanicolaou A, Agorastos T, Bontis JN ERBB2 (HER2) protein expression in uterine sarcomas Eur J Gynaecol Oncol 2009; 30: 292–294 (325) Zaloudek, C, Hendrickson MR, Soslow RA Mesenchymal tumors of the uterus In: Kurman RJ, Ellenson LH, Ronnett BM Blaustein’s Pathology of the Female Tract 6th edn Springer 2011; 452–527 (326) Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas Int J Gynecol Pathol 1999; 18: 20–28 (327) Zhao Z, Yoshida Y, Kurokawa T, Kiyono Y, Mori T, Okazawa H 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis J Nucl Med 2013; 54: 499–506 (328) Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on cancer staging systems J Clin Oncol 2009; 27: 2066–2072 (329) Zivanovic O, Jacks LM, Iasonos A, Leitao MM Jr, Soslow RA, Veras E, Chi DS, Abu-Rustum NR, Barakat RR, Brennan MF, Hensley ML A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma Cancer 2012; 118: 660–669 Image references Behrend F Evangelische Kliniken Bonn, Johanniterkrankenhaus, Abt Gynäkologie u Geburtshilfe Fig 2.1.9 (A), (B) Bernstein K, Hottenrott G Institut für Pathologie, Zytologie und Molekulare Diagnostik, Standort Eisenach/Westthüringen Fig 2.1.17 (B) Bettscheider J Krankenhaus Saarlouis vom DRK, Gynäkologisch-geburtshilfliche Abteilung, Saarlouis Fig 2.1.7 (C) Blohmer J Campus Charité Mitte, Klinik für Gynäkologie mit Brustzentrum, Berlin Fig 2.5.1 (C), (D) Blum J, Wenzel T Radiologische Allianz, Mörkenstr., Hamburg Altona Fig 2.1.18 (A) Engelhardt MCW Josephs-Hospital Warendorf, Abteilung Gynäkologie, Warendorf Fig 2.1.12 (A)–(C) Erler, MA GMP für Pathologie Krech/ Christians Osnabrück/Rheine, Rheine Fig 2.1.2 (A) Evert M, Evert K Universitätsmedizin Greifswald, Institut für Pathologie, Greifswald Fig 2.1.3 (A)–(H); 2.1.4 (A), (C)–(I); 2.1.7 (A); 2.1.13; 2.1.16 (A); 2.1.18 (B); 2.2.2 (C) Glaubitz M Klinikum Nordfriesland, Klinik Husum, Gynäkologie, Husum Fig 2.1.7 (B) Grimminger HJ, Missionsärztliche Klinik Würzburg, Gynäkologie und Geburtshilfe, Würzburg Fig 2.6.1 (A) Gürtler F Kreiskrankenhaus Wolgast, Abt Gynäkologie u Geburtshilfe, Wolgast Fig 2.1.1 (B) Heidkamp L Albertinen Krankenhaus Hamburg, Albertinen Frauenkliniken, Hamburg Fig 2.1.2 (D), (E) Hessler PA, Kuhfus S, Dennis K Krankenhaus Sachsenhausen, operative Gynäkologie, Frankfurt/Main Fig 2.1.1 (F); 2.1.9 (C), (D); 2.1.15 (A), (B) Hosten N, Hegenscheid K Universitätsmedizin Greifswald, Institut für Diagnostische Radiologie und Neuroradiologie, Greifswald Fig 2.1.1 (C); 2.1.10 (A)–(D); 2.1.19 (A), (D) Holthaus B Kardinal von Galen Kliniken, Krankenhaus ST Elisabeth, Gynäkologie, Damme Fig 2.1.8 (A)–(C) References | 229 Köhler G, Zygmunt M Universitätsmedizin Greifswald, Klinik Frauenheilkunde und Geburtshilfe, Greifswald Fig 2.1.1 (A), (D), (E); 2.1.2 (C); 2.1.4 (B); 2.1.11 (A), (B); 2.1.15 (E), (F); 2.1.16 (B)–(G) Krombach G Universitätsklinikum Gießen und Marburg, Diagnostische Radiologie, Gießen Fig 2.1.10 (E) Krystek E St Josefskrankenhaus Heidelberg, Gynäkologie und Geburtshilfe, Heidelberg Fig 2.1.2 (B) Kurz C Klinikum Esslingen, Klinik für Frauenheilkunde und Geburtshilfe, Esslingen Fig 2.1.5 (A), (B) Lampe B, Gröning T Florence-Nightingale-Krankenhaus, Klinik für Gynäkologie u Geburtshilfe, Düsseldorf-Kaiserswerth Fig 2.1.7 (G) Lehnhardt M Berufsgenossenschaftliches Univ.-Klinikum Bergmannsheil, Klinik f plastische Chirurgie, Bochum Fig 2.1.18 (C) Martin B Kliniken Landkreis Tuttlingen, Frauenklinik, Tuttlingen Fig 2.1.15 (C) Maurer C St Georg Klinikum Eisenach, Klinik f Frauenheilkunde u Geburtshilfe, Eisenach Fig 2.1.17 (A) Moeller H, Berger F Fachärzte f Frauenheilkunde, Lilienthal Fig 2.2.2 (A) Mustea A Universitätsmedizin Greifswald, Klinik Frauenheilkunde und Geburtshilfe, Greifswald Fig 2.1.15 (D); 2.1.19 (C); 2.2.2 (B) Naumann G HELIOS Klinikum Erfurt, Klinik für Frauenheilkunde und Geburtshilfe, Erfurt Fig 2.5.1 (A), (B) Niesel A Klinik Preetz, Gynäkolohie u Entbindung, Preetz Fig 2.1.8 (F) Praski A Marienhaus Klinikum Saarlouis, Klinik für Frauenheilkunde und Geburtshilfe, SaarlouisDillingen Fig 2.1.7 (H) Schwärzler P Asklepios Klinik Barmbek, Gynäkologie und Geburtshilfe, Hamburg Fig 2.1.8 (D), (E) Therre CH Albertinen-Krankenhaus, Klinik f Gynäkologie und Geburtshilfe, Hamburg Fig 2.1.18 (B) Widschwendter P Rotkreuzklinikum München, Gynäkologie, München Fig 2.1.7 (I), (J) Wisch B Regiokliniken, Klinikum Elmshorn, Gynäkologie, Elmshorn Fig 2.2.1 (A), (B) Wojdat R Mathilden Hospital Herford, Klinik Frauenheilkunde und Geburtshilfe, Herford Fig 2.1.14; 2.6.1 (B), (C) Wollensack S Ketteler Krankenhaus, Offenbach, Frauenklinik, Offenbach Fig 2.1.7 (F) Zeisberger, J Kreiskliniken Esslingen, Klinik Nürtingen, Klinik Frauenheilkunde u Geburtshilfe, Nürtingen Fig 2.1.6 (A), (B) Zieger W Schwarzwald-Baar Klinikum, Klinik Frauenheilkunde u Geburtshilfe, VillingenSchwenningen Fig 2.1.7 (D), (E) ... therapy | 47 Aftercare and follow-up, recurrences, metastases and their treatment | 53 Contents | 1. 10 1. 10 .1 1 .10 .2 1. 10.3 1. 11 1 .11 .1 1 .11 .2 1. 11. 3 1. 12 1. 12 .1 1 .12 .2 1. 12.3 1. 13 1. 13 .1 1 .13 .2... radiogenic therapy | X | Contents 1. 4 1. 4 .1 1.4.2 1. 4.3 1. 4.4 1. 5 1. 5 .1 1.5.2 1. 5.3 1. 6 1. 6 .1 1.6.2 1. 6.3 1. 7 1. 7 .1 1.7.2 1. 7.3 1. 8 1. 8 .1 1.8.2 1. 8.3 1. 9 1. 9 .1 1.9.2 1. 9.3 1. 9.4 Cellular leiomyoma | 10 ... 1. 12.3 1. 13 1. 13 .1 1 .13 .2 1. 13.3 1. 13.4 1. 14 1. 14 .1 1 .14 .2 1. 14.3 1. 14.4 1. 15 1. 15 .1 Leiomyoma, its variants and smooth muscle tumors with uncertain malignant potential of the vulva | 56 General,